Joel was Co-founder and CEO of C3i, a pharmaceutical services-focused company. As CEO, Joel expanded the company from zero to $100 million in annual revenue, with two thousand employees working in offices in the US, Bulgaria, India, China, and Japan. C3i was sold to Merck in 2014. Joel stayed on with Merck and was President of a combined $200 million subsidiary focused on both pharmaceutical and consumer services. Joel has an MBA from Columbia University and BSME from Tufts University.
Dave is a proven entrepreneur, operator, and board director with successful, strategic exits to public companies. Co-founder with Joel at C3i, Dave developed its sales, marketing, product development, and alliance strategies. Currently, Dave is an investor and serves as a board member and adviser to several start-ups and growth-stage companies in healthcare and technology.
Dr. Diamond is a Board Certified, Boston-based, ENT Surgeon/Otolaryngologist who was affiliated with Harvard Medical School and Massachusetts Eye and Ear Infirmary (MEEI) for over 30 years. She worked in a Medical Group Practice for 23 years and has considerable experience advising patients about entering clinical trials. She received her medical degree from the University of Rochester School of Medicine and completed her Otolaryngology/Head and Neck Surgery residency at MEEI.
Todd is a full-stack software engineer with a deep background in EHR system integration, Machine Learning, and large data analytics. Projects include META and IDseq for the Chan-Zuckerberg Initiative & launching the Kela Health program at Duke Medical.
Copyright © 2019 Curavit Clinical Research - All Rights Reserved.